[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100584841":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":19,"responsibleParty":53,"collaborators":10,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":22,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"University Hospital, Brest","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"patients with giant cell arteritis at diagnosis",null,"patients routinely monitored for their disease, and who typically benefit from temporal artery ultrasound as part of their disease. Recruitment will be facilitated by the fact that these are \"general population\" patients with suspected giant cell arteritis.",[13],{"name":14,"role":15,"phone":16,"phoneExt":17,"email":18},"Sandrine Pr JOUSSE-JOULIN","CONTACT","298347267","+33","sandrine.jousse-joulin@chu-brest.fr",[20,38],{"facility":21,"status":22,"city":23,"state":10,"zip":24,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":33},"Chu Brest","RECRUITING","Brest","29200","France","FR",{"type":28,"coordinates":29},"Point",[30,31],-4.48628,48.39029,{"lat":31,"lon":30},[34,36],{"name":14,"role":15,"phone":35,"phoneExt":17,"email":18},"0298347267",{"name":14,"role":37,"phone":10,"phoneExt":10,"email":10},"PRINCIPAL_INVESTIGATOR",{"facility":39,"status":22,"city":40,"state":10,"zip":41,"country":25,"countryCode":26,"cosmosGeoPoint":42,"geoPoint":46,"contacts":47},"Ch Quimper","Quimper","29107",{"type":28,"coordinates":43},[44,45],-4.09795,47.99597,{"lat":45,"lon":44},[48,52],{"name":49,"role":15,"phone":50,"phoneExt":17,"email":51},"Guillaume Dr DERRIEN","298526803","guillaume.derrien@ch-cornouaille.fr",{"name":49,"role":37,"phone":10,"phoneExt":10,"email":10},{"type":54,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100584841","association-of-ultrasonographic-temporal-artery-lesions-and-relapse-in-patients-with-giant-cell-arteritis-100584841",false,"NCT06894602","Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis","ALERT","Inclusion Criteria:\n\n* Major patient\n* Patients meeting ACR 2022 criteria for giant cell arteritis.\n* No opposition expressed\n\nExclusion Criteria:\n\n* Patients unable to understand the protocol, under guardianship or curatorship.\n* Patients not affiliated to the French Social Security system.","ALL","18 Years",{"count":65,"type":66},100,"ESTIMATED","OBSERVATIONAL","Ultrasound evaluation of the temporal and axillary arteries is currently well recognized in the field of giant cell arteritis (GCA), a disease primarily affecting medium- and large-caliber vessels. Structural ultrasound abnormalities are now well described in this pathology, but their association with relapse and clinical concordance is unknown. There is currently a follow-up score (the OGUS score) for medium- and large-caliber arteries that could also predict the clinical course of the disease.",[70],"Giant Cell Arteritis",[72,73,74,75,76],"giant cell arteritis","Ultrasound","follow up","monitoring","OGUS score","2026-03-18",{"date":79,"type":80},"2026-03-20","ACTUAL",{"date":82,"type":80},"2025-08-05",{"date":84,"type":66},"2028-08-01",{"name":5,"class":6},2]